About this event

  • Date and time Thu 22 Apr 2021 from 6:00pm to 7:30pm
  • Location Online
  • Organised by Medicine and Me, Action Against AMD

Jointly organised with Action Against AMD, this meeting will hear from people living with age-related macular degeneration (AMD) and from experts who work with people with AMD. 

AMD is one of the leading causes of blindness in the world. Around 10 million people have late-stage AMD globally. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD and, with an ageing world population, AMD cases are expected to double by 2040. 

We will be joined by a multidisciplinary faculty of speakers, with a patient perspective as well as expert clinicians and researchers to review and discuss current and future approaches to diagnosis and treatment of AMD in the light of an increased understanding of the biology, genetics and epidemiology.

What will you learn?

By attending this meeting, you will have the opportunity to:

  • Understand the "status quo" about AMD biology: one or many diseases?
  • Know about today’s treatments, their benefits and shortcomings
  • Know about the potential of addressing AMD at its early or intermediate stages
  • Understand the potential through “big data” of early recognition of those at risk from developing AMD
  • Understand the need for a new paradigm to address the challenge of AMD in an ageing population

CPD accredited: A CPD certificate with 2 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording. 

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed 

About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management. Physicians, surgeons and indeed all healthcare professionals, continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

We would like to thank our anonymous donor for their generous support enabling this platform for patient focused charities and free access to the Medicine and Me series

Key speakers

Pearse Keane (1)

Dr Pearse Keane

Consultant ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust, and Associate Professor, University College London, Institute of Ophthalmology

Speaker's biography

Pearse Keane is a consultant ophthalmologist at Moorfields Eye Hospital, London and an associate professor at UCL Institute of Ophthalmology. He is originally from Ireland and received his medical degree from University College Dublin (UCD), graduating in 2002. 


In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of developing artificial intelligence (AI) algorithms for the earlier detection and treatment of retinal disease. In August 2018, the first results of this collaboration were published in the journal, Nature Medicine.


In May 2020, he jointly led work, again published in Nature Medicine, to develop an early warning system for age-related macular degeneration (AMD), by far the most common cause of blindness in many


In October 2019, he was included on the Evening Standard Progress1000 list of most influential Londoners and in June 2020, he was profiled in The Economist


In 2020, he was listed on the “The Power List” by The Ophthalmologist magazine, a ranking of
the Top 100 most influential people in the world of ophthalmology.

Dawn Sim

Ms Dawn Sim

Consultant ophthalmologist, Director of Telemedicine, Moorfields Eye Hospital Associate Professor, Institute of Ophthalmology, UCL

Speaker's biography

Dawn Sim is a consultant ophthalmic surgeon specialising in Medical Retina and Cataract at Moorfields Eye Hospital.


A former chief resident at Moorfields, she currently holds the position of Director of Telemedicine and Joint Clinical Director of the Digital Clinical Laboratory there.


She is also an Associate Professor at the Institute of Ophthalmology at University College London and the programme director for Telemedicine and Digital health modules there.


View the programme

Welcome and introduction

Dr Wen Hwa Lee, CEO, Action Against Age-Related Macular Degeneration, and Ms Michele Acton, Chief Executive, Royal Society of Medicine

Macular degeneration from a patient perspective

Mrs Julie Parker

Age related macular degeneration: who gets it, why and what can we do today?

Dr Dawn Sim, Consultant Ophthalmologist, Director of Telemedicine at Moorfields Eye Hospital, and Associate Professor at UCL Institute of Ophthalmology

Big data, AI and AMD

Dr Pearse Keane, Consultant Ophthalmologist, Moorfields Eye
Hospital NHS Foundation Trust, and 
Associate Professor, Institute of Ophthalmology, University College London

Unmet need: focusing on early and intermediate AMD

Dr Wen Hwa Lee

Panel discussion

Chair: Ms Cathy Yelf, Chief Executive, Macular Society and Dr Wen Hwa Lee

Panellists: Mrs Julie Parker, Dr Dawn Sim, Dr Pearse Keane.

Close of meeting



Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member